
of course.. vested ...
XiaoMaGe888 ( Date: 29-Apr-2008 17:00) Posted:
|
would anyone happen to know what is going on?

jackjames ( Date: 28-Apr-2008 17:13) Posted:
|
16:45:49 | 0.690 | 114 | B |
16:45:48 | 0.690 | 102 | B |
16:45:42 | 0.690 | 30 | B |
16:45:40 | 0.690 | 40 | B |
16:45:26 | 0.690 | 500 | B |
16:45:23 | 0.690 | 300 | B |
16:45:04 | 0.690 | 5 | B |
16:44:54 | 0.690 | 100 | B |
16:44:32 | 0.695 | 10 | S |
16:42:21 | 0.690 | 100 | B |
Biosensor has fair value arround .665 base on market sentiment. You need to be patient to get in, and once it touches .7xx .. faster free yourself

You need to implement break-out strategy to have profit at price more than .7xx
I am on the queue at 0.69, 0.65, 20 lots, 20 lots, wish me luck...
0.695 now..
Then again is time to load up this baby when it touches 60cts region.... never go wrong with this tactic....
A few cycles prove that rebound from .60 to .80 region within 2 months..... a good 18% to 30% gain in portfolio... what a good deal right... but trade with care cos dunno what the FED is up to this time round with inflation to be the main concern...
cheers
exodus ( Date: 29-Apr-2008 12:10) Posted:
|
so close to flirting w/ 60+cents again...
This stock kena damaged because poor IPO handling, bad investor relations, too many punters playing contra/shorting, many long term investors left already. Very volatile share price, public float too big, etc. BIG already has 3 VCs put in US$45m cash more than a year ago under convertible loan stock scheme. I have looked around and so far no one can come close to BIG's technology yet. There are many "wild and revolutionary" claims of newer DESs. I feel many of them may not work or cannot get pass the clinical trial stage, let alone passing with flying colours. But I personally like Cardiomind's Sparrow DES for their ability to reach to vessels below 2mm. This DES can open up a lot of new demand for very small vessels previously cannot be reached by conventional balloon delivery system.
As for raising funds for global expansion or improving financial positions for takeover negotiations, I think BIG can tap on Terumo again because BIG has something that Terumo need and Terumo has the cash that BIG need. Alternatively, BIG can raise cash (vendor sale) via public listing of China JWMS subsidiary. BIG may be withholding this listing plan now because the second acquisition of 50% JWMS via share swap (announced on early Jan 2008) has not been completed yet. I think if BIG can work properly on just this 2 methods, BIG can easily have an extra US$200m cash in their bank. If that is the case, BIG will have / is going to have US$300m of cash to expand into global markets. Further penetrate deeper into Europe and Asia, form an alliance with an american company (I feel St Judes Medical can be a good candidate instead of the big 4 DES rivals) and go for North America market (40% of global DES sales), export cheap and good DES from China JWMS into 3rd world markets. If this global expansion program is successful, BIG will become a truly global DES powerhouse.
Hi Bengster
BIG can consider to interest VC or socalled Angels to come in and provide the funds if they really want to increase capital. I see BIG's prob is although its product currently might be one of the best around, prospective and serious VC might still think it will soon be overtaken by another new invention of one of the big players and thus believe too risky to join BIG. Reckon this is also the reason why its share price is still not doing well?
bengster68 ( Date: 28-Apr-2008 13:11) Posted:
|
which counter dont BS....all counter BS..... bro....

Piss JJ u got any?
